Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten J Postma

Showing results (181-190 of 485) with videos related to

Pageof 49
Sort By:
Plos One|January 23, 2016
Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast CancerEvgeni Dvortsin, Judith Gout-Zwart, Ernst-Lodewijk Marie Eijssen, et al.
Journal of Medical Economics|April 13, 2012
Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomesJanneke Jentink, Cornelis Boersma, Lolkje T W de Jong-van den Berg, et al.
Expert Review of Vaccines|November 23, 2012
Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptionsRaymond A Farkouh, Rogier M Klok, Maarten J Postma, et al.
Plos One|January 26, 2013
Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed dataBaudouin Standaert, Jorge A Gomez, Marc Raes, et al.
Therapeutics and Clinical Risk Management|October 29, 2020
Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in IndonesiaAuliya A Suwantika, Angga P Kautsar, Neily Zakiyah, et al.
International Journal of Methods in Psychiatric Research|December 10, 2014
Evaluation of health promotion programmes in severe mental illness: theory and practiceFenneke M van Hasselt, Paul F M Krabbe, Maarten J Postma, et al.
Clinical Therapeutics|May 17, 2003
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The NetherlandsBen A van Hout, Rogier M Klok, Jacobus R B J Brouwers, et al.
The Lancet. Infectious Diseases|February 14, 2016
Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysisMaarten van Wijhe, Scott A McDonald, Hester E de Melker, et al.
BMJ Public Health|June 27, 2025
Cost-effectiveness of treatment with finerenone in mild to advanced stage chronic kidney disease patients with type 2 diabetes from a societal perspectiveSara Wilhelmien Quist, Jeanni van Loon, Stephan Bakker, et al.
BMJ Open Respiratory Research|November 10, 2023
Multidisciplinary tuberculosis care: leveraging the role of hospital pharmacistsDeni Iskandar, Ivan S Pradipta, Ani Anggriani, et al.
Pageof 49

Showing results (181-190 of 485) with videos related to

Sort By:
Pageof 49
Plos One|January 23, 2016
Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast CancerEvgeni Dvortsin, Judith Gout-Zwart, Ernst-Lodewijk Marie Eijssen, et al.
Journal of Medical Economics|April 13, 2012
Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomesJanneke Jentink, Cornelis Boersma, Lolkje T W de Jong-van den Berg, et al.
Expert Review of Vaccines|November 23, 2012
Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptionsRaymond A Farkouh, Rogier M Klok, Maarten J Postma, et al.
Plos One|January 26, 2013
Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed dataBaudouin Standaert, Jorge A Gomez, Marc Raes, et al.
Therapeutics and Clinical Risk Management|October 29, 2020
Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in IndonesiaAuliya A Suwantika, Angga P Kautsar, Neily Zakiyah, et al.
International Journal of Methods in Psychiatric Research|December 10, 2014
Evaluation of health promotion programmes in severe mental illness: theory and practiceFenneke M van Hasselt, Paul F M Krabbe, Maarten J Postma, et al.
Clinical Therapeutics|May 17, 2003
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The NetherlandsBen A van Hout, Rogier M Klok, Jacobus R B J Brouwers, et al.
The Lancet. Infectious Diseases|February 14, 2016
Effect of vaccination programmes on mortality burden among children and young adults in the Netherlands during the 20th century: a historical analysisMaarten van Wijhe, Scott A McDonald, Hester E de Melker, et al.
BMJ Public Health|June 27, 2025
Cost-effectiveness of treatment with finerenone in mild to advanced stage chronic kidney disease patients with type 2 diabetes from a societal perspectiveSara Wilhelmien Quist, Jeanni van Loon, Stephan Bakker, et al.
BMJ Open Respiratory Research|November 10, 2023
Multidisciplinary tuberculosis care: leveraging the role of hospital pharmacistsDeni Iskandar, Ivan S Pradipta, Ani Anggriani, et al.
Pageof 49